Home/Filings/4/0001209191-22-024536
4//SEC Filing

Mahadevan Chids 4

Accession 0001209191-22-024536

CIK 0001697532other

Filed

Apr 14, 8:00 PM ET

Accepted

Apr 15, 7:08 PM ET

Size

7.9 KB

Accession

0001209191-22-024536

Insider Transaction Report

Form 4
Period: 2022-04-13
Mahadevan Chids
Chief Accounting Officer
Transactions
  • Award

    Common Stock

    2022-04-13+2,13610,705 total
  • Award

    Employee Stock Option (Right to Buy)

    2022-04-13+19,05819,058 total
    Exercise: $2.02Exp: 2032-04-13Common Stock (19,058 underlying)
Footnotes (2)
  • [F1]Consists of compensatory Restricted Stock Units granted under Applied Therapeutics, Inc.'s 2019 Equity Incentive Plan. Each compensatory Restricted Stock Unit represents a contingent right to receive one share of the issuer's common stock. One-fourth (1/4th) of the compensatory Restricted Stock Units shall vest on April 13, 2023, and one-twelfth (1/12th) of the remaining shares subject to the compensatory Restricted Stock Units shall vest each quarter thereafter, subject to the Reporting Person continuing to provide services through each such date.
  • [F2]Consists of compensatory Options granted under Applied Therapeutics, Inc.'s 2019 Equity Incentive Plan. One-fourth (1/4th) of the shares subject to the compensatory Option shall vest on April 13, 2023, and one thirty-sixth (1/36th) of the remaining shares subject to the compensatory Option shall vest each month thereafter, subject to the Reporting Person continuing to provide services through each such date.

Issuer

Applied Therapeutics Inc.

CIK 0001697532

Entity typeother

Related Parties

1
  • filerCIK 0001808486

Filing Metadata

Form type
4
Filed
Apr 14, 8:00 PM ET
Accepted
Apr 15, 7:08 PM ET
Size
7.9 KB